Insulin-dependent diabetes mellitus (IDDM) is associated with abnormal function of the vascular endothelium and it is proposed that this defect could underlie many of the associated vasculopathies [1] . Studies from our laboratory and others have reported impaired vasodilatory responses to the endothelium-dependent vasodilator acetylcholine (ACh) in isolated arteries from diabetic subjects [2] and in mesenteric [3] , femoral [4] and aortic [5] arteries from the streptozotocin (STZ)-diabetic rat (an animal model of uncontrolled IDDM). Although a physiological endothelium-dependent dilatory role of ACh has sometimes been questioned, the reduced relaxation of arteries from diabetic animals to other endothelium-dependent dilators [1] and to increasing luminal flow [6] would suggest that the poor ACh responses reflect a generalised endothelial defect. The abnormal ACh response is likely to result from either decreased nitric oxide (NO) synthesis or increased NO degradation [3, 4] . Several mechanisms have been hypothesised, among which is the suggestion that oxidative stress could play an important role [7, 8] . Diabetologia (1998) Summary Impaired endothelium-dependent relaxation could underlie many of the vascular complications associated with insulin-dependent diabetes mellitus, and may be mediated by increased oxidative stress. The effect of antioxidants on vascular endothelial function and oxidative stress of streptozotocin-diabetic rats was assessed by dietary supplementation with vitamins E and C. Diabetic (i. v. streptozotocin, 45 mg/kg) male Sprague-Dawley rats were fed one of six supplemented diets containing 75.9, 250, or 500 mg vitamin E/kg chow, 250 mg vitamin C/kg H 2 0, 250 mg vitamin E/kg chow plus 250 mg vitamin C/kg H 2 O, or chow deficient in vitamin E, and then compared to standard-fed control rats. After 4 weeks, small mesenteric arteries were dissected and mounted on a small vessel myograph, concentration response curves were then constructed to noradrenaline, acetylcholine and sodium nitroprusside. Acetylcholinemediated relaxation was impaired in arteries from diabetic rats (pEC 50 6.701 ± SEM 0.120, n = 8) compared to controls (7.386 ± 0.078, n = 6; p < 0.05). The 500 mg/kg vitamin E diet further impaired maximum relaxation to acetylcholine (58.2 ± 10.5 vitamin E, n = 7 vs 84.4 ± 5.3 % standard, p < 0.05), and the combined vitamin E plus C diet impaired maximum relaxation to sodium nitroprusside (48.5 ± 4.1 in vitamin E + C, n = 8 vs 75.6 ± 3.9 % standard; p < 0.01). However, plasma 8-epi-prostaglandin (PG)F 2 a (measured as an estimate of oxidative stress) was dose-dependently decreased in rats on vitamin E supplemented diets. Dietary antioxidant supplementation did not reverse impaired endothelial function in this model of uncontrolled diabetes despite a concomitant decrease in oxidative stress. [Diabetologia (1998) 41: 148±156] 
Oxidative stress may occur as a result of increased free radical generation, decreased levels of antioxidants and/or impaired regeneration of reduced forms of antioxidants. Evidence for oxidative stress in diabetes includes observations of decreased antioxidant plasma concentrations in both diabetic subjects [9] and animal models of diabetes [10] , and reports of increased free radical-generated plasma lipid peroxides [11] . There are studies, however, which suggest that vitamin E plasma and tissue levels may be raised in both IDDM [12] and the STZ rat [13] , possibly as a compensatory response to increased free radical lipid peroxidation. Free radicals may be responsible for damage to DNA, oxidative modification of lipids including low-density lipoprotein (LDL), and have been implicated in glycation and protein modification reactions that contribute to tissue damage in diabetes [14] . LDL in its native or oxidised state can impair endothelium-dependent relaxation [15] , and oxidised LDL may be toxic to cells [11] and decrease expression of endothelial NO-synthase [16] . Lipid peroxidation resulting from oxidative stress may be assessed by measurement of the recently described F 2 -isoprostanes [17] . These free radical-catalysed isomers of arachidonic acid are stable products of lipid peroxidation which are present in human plasma and are excreted in the urine [18] . Concentrations of the isoprostane, 8-epi-prostaglandin(PG)F 2a , are raised in the plasma of non-insulin-dependent diabetic subjects [19] and in heavy smokers [20] . In addition, 8-epi-PGF 2a is a potent constrictor of the coronary circulation [21] .
Theoretically, therefore, antioxidant supplementation may be of benefit to vascular function in diabetes. In the Cambridge Heart Antioxidant Study (CHAOS), vitamin E supplementation has been shown to be of some benefit in non-diabetic patients with coronary artery disease as it decreased the rate of non-fatal myocardial infarction [22] . Some therapeutic potential for dietary antioxidant supplementation has also been inferred from studies of conduit arteries [5, 23] and of sciatic nerve endoneurial blood flow in animal models of diabetes [24] .
The aim of this study was to determine whether this beneficial effect of antioxidant dietary supplementation on vascular function also occurs in isolated small arteries in an animal model of diabetes. A combination of vitamin E with vitamin C was chosen since vitamin C, as well as being a free radical scavenger, also regenerates vitamin E to its active form [25] . The effect of dietary vitamin E and C supplementation on STZ-rat mesenteric small artery function was investigated, and liver and plasma content of vitamin E after dietary supplementation were measured. Plasma and liver concentrations of 8-epi-PGF 2a were estimated in each group of animals as an indicator of oxidative stress.
Materials and methods
The animal procedures in the following protocol were carried out under Home Office (UK) license number PPL 90 764, and the`Principles of laboratory animal care' (NIH publication No. 85±23, revised 1985) were followed.
Induction of experimental diabetes. Diabetes was induced in male Sprague-Dawley rats (250±300 g) by caudal intravenous injection of STZ (45 mg/kg) dissolved in citrate buffer (0.1 mol/l trisodium citrate, 0.1 mol/l citric acid). Control animals were injected with vehicle alone. Development of diabetes was confirmed by the presence of glycosuria 3 days after injection. In the fifth week after injection animals were killed by inhalation of CO 2 and cervical dislocation. Cardiac puncture was performed to obtain blood samples for the measurement of plasma glucose with an enzymatic ultra violet test, using an HK/G6P-DH method (Cobas Fara Centrifugal analyser; Roche Diagnostic Systems, Welwyn Garden City, UK). Animals were housed individually and provided with food and water ad libitum.
Dietary protocol. The animals were divided into seven groups and supplemented diets commenced 3 days after injection of either STZ or vehicle. Groups 1 and 2 were fed standard diet (75.9 mg vitamin E/kg chow): 1) control non-diabetic rats (n = 6); 2) diabetic rats (n = 8).
The remaining groups of diabetic rats were fed the following supplemented diets: 3) 250 mg vitamin E/kg chow (n = 6); 4) 500 mg vitamin E/kg chow (n = 7); 5) vitamin E deficient chow (n = 6); 6) 250 mg vitamin C/kg drinking water, and standard diet (n = 6); 7) 250 mg vitamin C/kg drinking water + 250 mg vitamin E/kg chow (n = 8).
Weight of food consumed and animal weight were recorded twice weekly, and concentration of vitamin C was based on the observed daily consumption of approximately 500 ml H 2 O per rat. In addition, a group of control non-diabetic animals (n = 6) were fed 500 mg vitamin E/kg supplemented diet, and vascular function compared with the control animals on standard chow from group 1.
Assessment of vascular function. The small intestine and intact mesentery were removed from the animal and placed in cold physiological salt solution (PSS) [(mmol/l): 119 NaCl; 25 NaH-CO 3 ; 5.5 d-glucose; 1.18 KH 2 PO 4 ; 1.17 MgSO 4 ; 4.7 KCl; 2.5CaCl 2 ; 0.026 EDTA, ethylenediamine-tetra-acetic acid disodium salt]. Third-order branches of the mesenteric tree were dissected free of connective tissue and mounted in pairs as ring preparations on a small vessel myograph for the measurement of isometric tension. The methods have been described in detail previously [3, 26] . Briefly, arteries were bathed in PSS, gassed with 5 % CO 2 / 95 % O 2 at 37°C (pH 7.45), and their passive tension and internal circumference determined. The arteries were then set to an internal circumference equivalent to 90 % of that which they would experience when relaxed in situ under a transmural pressure of 100 mmHg (the maximum active tension for the minimum resting tension is developed at approximately this circumference). Arteries were then subjected to a routine`run-up' procedure including a total of five contractions to noradrenaline (NA, 5 mmol/l), 125 mmol/l potassium solution (KPSS; PSS with equimolar substitution of KCl for NaCl) and 5 mmol/l NA in KPSS. In the fifth contraction, arteries that reached an effective pressure of 100 mmHg (13.3 kPa) were regarded viable and all arteries in this study satisfied this inclusion criteria. Concentration-effect curves were constructed to NA (0.1±10 mmol/l), with concentration increments at 2 min intervals. Following repeated washing and recovery (10 min) arteries were submaximally contracted with NA to achieve approximately 80 % of the maximum response. Endothelial function was assessed by addition of half log molar increments of ACh at 2 min intervals (10 -9 ±10 ±5 mol/l). A similar protocol was followed to assess endothelium-independent vasodilatation, by assessing relaxation to SNP (10 -9
±10
±5 mol/l).
Assessment of oxidative stress. Tissue and blood samples were taken for analysis of vitamin E and 8-epi-PGF 2 a. Liver lobes were removed from the animal, snap frozen in liquid nitrogen and stored at ±70°C. Blood samples were obtained by cardiac puncture. Samples for 8-epi-PGF 2 a and vitamin E were collected into 3.8 % sodium citrate (blood/anticoagulant ratio 9:1) and 14 mmol/l indomethacin (in 5 % sodium bicarbonate). Samples were centrifuged after standing at 4°C for 45 min, (2400 g, 15 min, 4°C) and aliquots of the supernatant were stored in butylated hydroxytoluene (BHT, 20 mmol/l in ethanol, ±70°C) until analysis [27] .
Total (sum of free and esterified) F 2 -isoprostanes in plasma and liver. Due to the limited volumes of plasma available, samples were pooled, and extraction and analysis was then performed in triplicate. Liver measurements were performed in duplicate on samples of tissue from each rat. Plasma (1 ml) was incubated with an aqueous solution of potassium hydroxide (1 ml, 1.0 mol/l, 40°C for 30 min) to hydrolyse esterified F 2 isoprostanes. Water (1 ml) was then added and the pH adjusted with HCl to pH 3.0. PGF 2 ±d 4 (5 ng in 50 ml ethanol) was added as an internal standard and the sample centrifuged (2400 g, 5 min).
The supernatant was applied to a C-18 cartridge (500 mg) preconditioned with methanol and water (pH 3.0) and the cartridge then washed sequentially with 10 ml water (pH 3.0) and acetonitrile /water (15:85 v/v) to remove polar material. Lipids were eluted by washing with 5 ml hexane/ethyl acetate/propan-2-ol (30:65:5 v/v). This eluate was then applied to an NH 2 cartridge preconditioned with hexane (5 ml) which was then washed sequentially with 10 ml of hexane/ethylacetate (30:70 v/v), acetonitrile/ water (90:10 v/v) and acetonitrile. F 2 isoprostanes were eluted from the NH 2 cartridge with 5 ml of ethyl actetate/methanol/acetic acid (10:85:5 v/v) and the eluate immediately evaporated under nitrogen at room temperature. Liver samples (0.8±1.1 g) were homogenised in ice-cold chloroform/methanol solution (2/1 v/v with BHT, 0.005 %). Sodium chloride (0.9 %) was added and the lipid containing chloroform fraction isolated. After solvent evaporation, the lipids were subjected to hydrolysis (30 min, 40°C with potassium hydroxide, 1.0 mol/l). The sample was then divided for vitamin E and isoprostane analysis. For isoprostanes, the solution was neutralised with HCl (2 ml, 1.0 mol/l), acidified to pH 1.0 with HCl (0.1 mol/l), vortex mixed, centrifuged (1118 g) and then filtered. Internal standard (PGF 2 -d 4 , 5 ng) was added and the samples were loaded onto C-18 cartridges as above.
Derivitisation and gas chromatography-mass spectrometry (GC-MS). Pentafluorobenzyl (PFB)-ester was prepared by adding 40 ml PFB (10 % in acetone) and 20 ml of diisopropylethylamine (DIPEA) (10 % in acetone) to the dried eluate. The vial was then sealed with a Teflon-lined cap and incubated (40°C, 45 min). The solvent was removed under a stream of nitrogen and trimethylsilyl (TMS)-ethers prepared by incubation of the dried sample with 50 ml N, O-bis(trimethylsily) trifluoroacetamide (BSTFA) and 5 ml DIPEA (10 % in acetone; 4°C, overnight). After removing excess solvent with nitrogen, the derivitised sample was reconstituted in iso-octane (40 ml, with 10 % BSTFA) and analysed immediately by gas chromatography-mass spectrometry (GC-MS). This was carried out with a Hewlett Packard 5890 gas chromatograph (Bracknell, UK) linked to a VG70SEQ mass spectrometer (Fisons Instruments, Manchester, UK), using ammonia as reagent gas. F 2 isoprostanes were separated on an SPB-1701 column (30 m´0.25 mm i.d´0.25 mm D f , Supelco, Penn, USA). Samples (2 ml) were injected automatically into a temperature programmed Gerstal injector (Thames Chromatography, Maidenhead, UK). The GC oven was programmed from 175±270°C at a rate of 30°C/min. Quantitative analysis was performed using selected ion monitoring (SIM) of the carboxylate ion [m-181] ± at m/z 569 for the F 2 -isoprostanes and m/z 573 for PGF 2 -d 4 .
Plasma and liver vitamin E analysis. Liver vitamin E content was assessed in individual samples and plasma concentrations were measured in duplicate from individual plasma samples. d-tocopherol (50 ml) was added, as an internal standard, to 0.5 ml of the treated plasma sample or liver extract (see above). Following addition of water (0.5 ml) and hexane (1 ml) the solution was vortexed and centrifuged (1118 g). The hexane layer was removed and dried under nitrogen. The extract was reconstituted in 100 ml of acetonitrile and transferred to WISP autoinjector vials (Waters, Milford, MA, USA). An aliquot (40 ml) was injected onto a high pressure liquid chromatograph (HPLC) and detection carried out using fluorescence as described previously [28] .
Materials. Chemicals used in this study were: NA (Sanofi Winthrop Ltd, Guildford, Surrey, UK); ACh, SNP, citric acid, trisodium citrate, BHT, indomethacin, metaphosphoric acid, PFBBr and DIPEA (Sigma-Aldrich Co. Ltd, Poole, Dorset, UK); STZ (gift from Dr. MacLeod, UpJohn Co. Kalamazoo, Mich., USA); Prostaglandin F 2 -d 4 from Cayman Chemicals (Ann Arbor, MI, USA); Sep-Pak C-18 and aminopropyl (NH 2 ) cartridges were from Waters Chromatography (Watford, Herts., UK); BSTFA from Pierce Chemical Company (Rockford, Ill., USA). All other chemicals were obtained from Merck Ltd, Poole, Dorset, UK and were of analytical grade. For the vascular protocols, all concentrations are expressed as their final molar concentrations in the vessel chamber. Supplemented diets were prepared by Special Diet Services, Witham, Essex, UK. The vitamin E content of the standardª rat and mouse no.1 maintenance dietª (R + M1) was 75.9 mg/kg, and this was supplemented with a-tocopherol acetate as required. Vitamin C (L-ascorbic acid, 99 %) was obtained from Sigma-Aldrich. Rats were approximately 12 weeks old at the beginning of the study and were obtained from Bantin and Kingman, Universal Ltd (Aldbrough, HuU, UK), UK.
Data calculation and statistical analysis. All values are given as mean ± SEM. For vascular protocols tension is given as the active wall tension (mN/mm artery length) and the relaxation responses to ACh and SNP were calculated as a percentage of initial preconstriction to NA. For ACh and NA responses the negative log of the concentration of a drug required to produce 50 % of the maximum response (pEC 50 ) was calculated for each artery. Two arteries were used from each animal and mean values calculated. n refers to the number of animals used. The individual pEC 50 was calculated using non-linear regression, and the sigmoid equation of a curve fitting program (GraphPad Software, San Diego, CA, USA). Where calculation of pEC 50 was not appropriate (for responses to SNP) or where maximal responses were blunted, summary measures were calculated [29] . The summary measure represents the mean of the values obtained for relaxation at each individual concentration in the concentration response curve. Comparisons were made between mean pEC 50 values and summary measures of all groups (InStat GraphPad, GraphPad Software) by ANOVA, using the Dunnett's correction for multiple comparisons with diabetic standard as control. Statistical analysis of tissue and plasma isoprostane and vitamin E data was carried out using the Dunnett's correction for multiple comparisons, or the unpaired Student's t-test when data from only two groups was being compared. Significance was assumed at p = 0.05.
Results
Plasma glucose was significantly elevated in diabetic animals when compared to controls (Table 1) . There was no significant difference in plasma glucose concentrations between any of the treated diabetic groups. While all animals gained weight over the 28 day dietary supplementation period, all the diabetic groups gained significantly less weight than the control group (mean weight of control 363.7 ± 10.8 g vs standard diabetic 315 ± 13.0 g ; p < 0.05). There was no significant difference in weights between diabetic groups on different diets. Food consumption averaged 65.6 ± 9.24 g daily and did not differ between control and diabetic groups.
Vascular function in diabetic and control rats on standard diet. Mean arterial internal diameter was 304.1 ± 6.9 mm (n = 103 arteries). There was no statistical difference in artery diameter between the groups. Preconstricted mesenteric arteries from both control and diabetic rats relaxed in a concentration dependent manner to ACh. The arteries from diabetic animals on the standard diet demonstrated a significant reduction in sensitivity (pEC 50 ) to ACh when compared to controls ( Fig. 1a; Table 2 ). There was no significant difference in the sensitivity of arteries from diabetic and control rats to NA or to SNP (Table 2).
Vascular function in rats on vitamin E deficient diet.
There was no observed difference in ACh responses of arteries from the vitamin E-deficient rats when compared to the standard diabetic rats (Fig. 1 a) and no significant difference in responses to SNP (Fig. 1 b) or NA ( Table 2) .
Vascular function in rats on dietary vitamin E supplementation. Arteries from rats maintained on the 250 mg/kg vitamin E supplemented diet responded similarly to arteries from diabetic rats on the standard diet. There was no significant difference in response to either ACh (Fig. 1 a) , SNP (Fig. 1 b) or NA ( Table 2 ). In contrast, arteries from animals fed the 500 mg/kg vitamin E chow displayed a further 
Data are mean ± SEM a p < 0.001 compared to control impairment in relaxation to ACh as assessed by summary measure, compared with the diabetic rats on the standard diet ( Fig. 1a ; Table 2 ). Responses to SNP appeared impaired when compared to standard (Fig. 1 b) but this did not reach statistical significance. No differences in responses to NA were observed between the groups (Table 2) .
Vascular function in diabetic rats on vitamin C supplementation. Vitamin C supplementation alone did not significantly improve relaxation of arteries to ACh (Fig. 2 a) , and had no effect on responses to either SNP (Fig. 2 b) or NA ( Table 2) .
Vascular function in diabetic rats on combined vitamin E and C supplementation. Arteries from rats fed both vitamin E and C did not demonstrate an improvement in their responses to ACh (Fig. 2 a) , and there was no difference in responses to NA when compared to controls (Table 2) . However, the relax- ation to SNP was significantly impaired when compared to standard diabetic rats as assessed by summary measures ( Fig. 2b; Table 2 ).
Vascular function in control rats fed on vitamin E (500 mg/kg). Control non-diabetic animals fed for 4 weeks on the high vitamin E diet demonstrated a blunted sensitivity to ACh when compared to control non-diabetic animals fed normal diet (pEC 50 control non-diabetic rats; 500 mg vitamin E/kg 6.959 ± 0.136, n = 6 vs standard diet 7.386 ± 0.078, n = 6; p < 0.05) (Fig. 3) . No changes in responses to NA or SNP were observed.
Liver and plasma vitamin E. Limited samples were available for liver and plasma vitamin E (a-tocopherol) estimation as preference was made for isoprostane analysis. Liver vitamin E was not different between control non-diabetic rats and diabetic rats on a vitamin E deficient diet (1.98 ± 0.08 in controls, n = 4 vs 1.70 ± 0.30 mg/g in deficient, n = 3; NS). Vitamin E estimations were not carried out for intermediate supplementation doses, but liver content was significantly raised in rats on 500 mg/kg vitamin E (13.33 ± 1.05 mg/ g, n = 3; p < 0.01) when compared to non-diabetic controls. There was also a significant increase in plasma vitamin E concentration in 500 mg/kg vitamin E fed rats when compared to diabetic rats on standard chow (12.62 ± 0.53 in 500 mg/kg vitamin E, n = 4 vs 1.68 ± 0.32 mmol/l in standard diabetic, n = 3; p < 0.0001).
Plasma concentrations of 8-epi-PGF 2a . The plasma concentration of 8-epi-PGF 2a was 0.58 ± 0.06 nmol/l in plasma from diabetic rats on standard chow (n = 3) but was below the level of detection (0.03 nmol/l) in plasma from control non-diabetic rats (n = 4). The plasma concentration of 8-epi-PGF 2a was significantly greater in rats on a vitamin E deficient diet (0.79 ± 0.05 nmol/l, n = 5 vs standard diabetic; p < 0.05) and there was a significant decrease in plasma concentration (0.22 ± 0.02 nmol/l, n = 3; p < 0.01) of the 250 mg/kg vitamin E treated group when compared to that of the standard diabetic group. Plasma 8-epi-PGF 2a was below the detection limit of 0.03 nmol/l in those animals treated with 500 mg/kg vitamin E (n = 4) or a combination of vitamin E and C (n = 6) (Fig. 4 a) . Liver content of 8-epi-PGF 2a . There was a reduction of 8-epi-PGF 2a in the livers of the 250 mg/kg vitamin E fed diabetic rats compared with those on standard diet (2.00 ± 0.20 in 250 mg/kg vitamin E, n = 4 vs 4.96 ± 1.25 ng/g tissue in standard diabetic, n = 4; p < 0.05). 8-epi-PGF 2a levels were also decreased in rats on combined vitamin E and C, when compared to those on standard diet (1.61 ± 0.37 ng/g tissue in vitamin E + C group, n = 7; p < 0.01) (Fig. 4 b) .
Discussion
This study reports that the defect in ACh-induced endothelium-dependent relaxation in small mesenteric arteries from the STZ-rat, demonstrated in this and previous studies [1] , was not reversed by vitamin E dietary supplementation. Indeed, the higher dose of vitamin E (500 mg/kg diet) caused further attenuation of the vasodilatory response to ACh. This occurred despite the concomitant fall in levels of the isoprostane 8-epi-PGF 2a in plasma and liver, indicative of decreased oxidative stress. These data strongly suggest that vascular dysfunction in this animal model of diabetes is unlikely to be mediated by oxidative stress. In addition, this study is the first to use isoprostanes as markers of oxidative stress in the STZ-diabetic rat model of IDDM and to show that elevated plasma and tissue levels are reversed by antioxidant supplementation. To our knowledge only one study [20] has shown previously that 8-epi-PGF 2a concentration may be reversed by antioxidant supplementation. Two studies have previously reported beneficial effects of dietary vitamin E supplementation in the STZ-rat model of uncontrolled IDDM although both used a higher dose. These showed improvement of coronary vessel endothelial function and blood flow [23] , and of ACh-induced dilatation in aorta [5] . Inadequate supplementation was not likely to account for the lack of improvement of vascular function in this study as both liver and plasma vitamin E increased significantly after supplementation. An alternative, but we consider unlikely, explanation for the variance of these results to others could lie in the relative contribution of different dilator agents to ACh-induced relaxation in conduit and small arteries, such as endothelium-derived hyperpolarising factor, NO, and PGI 2 .
In common with the present study in which vitamin E supplementation further impaired vascular endothelial function in the diabetic rats, deleterious effects of vitamin E have been reported in a study of hypercholesterolaemic rabbits [30] . In these animals, defective ACh-mediated endothelium-dependent relaxation was present and low dose a-tocopherol improved, but high dose a-tocopherol further impaired the ACh-mediated relaxation of the aorta. Furthermore, vascular function (determined by forearm venous occlusion plethysmography) [31] did not improve in hypercholesterolaemic patients on supplements of 400 mg vitamin E/day over 8 weeks. In both studies, despite the variable vascular responses to vitamin E supplementation, a decreased susceptibility of plasma-derived LDL to copper-induced oxidation in response to Cu 2 + ions indicated effective reduction of oxidative stress.
Few of the earlier studies of vitamin E supplementation in animals determined whether it affects endothelial function in controls, but the control rats fed on the higher of the vitamin E supplemented diets in this study developed a defect in endothelium-dependent relaxation, the shift in the response being of similar magnitude to that observed in the diabetic rats fed the same diet. Excessive antioxidant treatment per se may therefore be deleterious to vascular function in normal rats.
The rationale for the use of combined vitamin E and C in one of the groups of diabetic rats lies in the vital role that vitamin C is considered to play in the regeneration of a-tocopherol [25] . Plasma 8-epi-PGF 2a concentrations in diabetic animals on the combined vitamin E (250 mg/kg) plus C diet were decreased to a level significantly lower than in the 250 mg/kg vitamin E supplemented rats, which implies that recycling of vitamin E by vitamin C had indeed occurred. Despite this, a significant impairment in relaxation to SNP was observed in arteries from combined vitamin E and C treated rats and no improvement in ACh-induced relaxation was observed in either combined vitamin E plus C or vitamin C alone treated diabetic rats. Previous studies of vitamin C supplements on diabetic vascular dysfunction are few, but minimal benefit of vitamin C supplementation has been reported in a study of peripheral nerve and neurovascular function in diabetic rats [24] together with an additive effect of combined vitamin E and C in the prevention of reduced motor nerve conduction velocity. A possible explanation for the lack of response to vitamin C alone in the STZ-rat could be that endogenous synthesis of the vitamin is sufficient to prevent depletion. However, the STZ-rat has been reported to be ascorbic acid deficient [10] and would, theoretically, benefit from supplementation.
The mechanism behind the deleterious action of vitamin E in these studies is unclear, but as the defect lay at the level of both endothelium-dependent and independent relaxation, it may represent excessive NO degradation. NO (itself a free radical) could be directly scavenged by the high concentrations of a-tocopherol present in the plasma membrane of vascular smooth muscle cells of the treated animals [32, 33] . The further impairment of vascular function in rats on the combined vitamin E and C diet may reflect the increased availability of reduced vitamin E to quench NO. In the diabetic rabbit aorta [34] but not in the diabetic rat small mesenteric artery [3] , synthesis of constrictor prostanoids counteracts ACh-induced relaxation. In the present study we did not include the use of cyclooxygenase inhibitors and therefore we cannot exclude the possibility that vitamin E may have led to de novo synthesis of constrictor prostanoids in response to ACh.
The relevance of the effects of antioxidant supplementation in rat mesenteric arteries to responses in other vascular beds and other species must be considered. Since the defect of ACh-induced relaxation is common to other vascular beds of the STZ rat [3±5] and to arteries of the subcutaneous circulation in diabetic subjects [2] we consider that the data in this study may be pertinent to other circulations, and indeed to diabetic patients.
In conclusion, although antioxidant therapy ameliorates oxidative stress, it does not improve vascular endothelial dysfunction in the small mesenteric arteries of the STZ diabetic rat. At high doses, vitamin E may have deleterious effects in the vasculature of normal animals and this observation should be of concern in any study in which antioxidant therapy is employed. Vitamin E metabolism in disease and the question of dose are obviously crucial issues and need further investigation before it can be recommended with confidence as a dietary supplement.
